Medartis Granted 510(k) for CalcShift Displacement Calcaneal Osteotomy System

Medartis received FDA 510(k) clearance to market its CalcShift System for displacement calcaneal osteotomies. The system is one of several new lower extremity products scheduled for launch in the U.S. in 2023.

Indicated for osteotomies, non-unions, malunions, revisions, fusions and reconstruction of the calcaneus requiring a medial or lateral...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us